IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (8)
Leerink Partners
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11 | 89bio Inc. | Health-Care | 16 | 5 | BAML | LRNK | RBC | 4.6% | 30% | ||
| Nov 7 | Centogene B.V. | Health-Care | 14 | 4 | LRNK | EVCR | 23.2% | -10.8% | |||
| Jul 25 | Castle Bioscien | Health-Care | 16 | 4 | LRNK | BARD | 53.9% | 33.8% | |||
| Jul 18 | Fulcrum Therape | Health-Care | 16 | 4 | MS | BAML | LRNK | 27.6% | -15.6% | ||
| May 7 | Trevi Therapeut | NA | 10 | 5 | LRNK | Stifel | BMO | 24.9% | -21.1% | ||
| Apr 17 | Turning Point T | NA | 18 | 9 | GS | LRNK | WLFG | 34.2% | 60.6% | ||
| Feb 8 | Harpoon Therape | NA | 14 | 5 | CITI | LRNK | 24.3% | -3.6% | |||
| Feb 8 | Gossamer Bio In | NA | 16 | 17 | BAML | LRNK | BRCL | 34.2% | 12.1% | ||
*
Lead manager or one of top three managers in an underwriting team.